Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Clinical trial NCT01383447 · TERMINATED
Trial details
- NCT number
- NCT01383447
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-04-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.